World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
127
Citations
68515
World Ranking
262
National Ranking
170

Medicine

D-Index
129
Citations
70636
World Ranking
2567
National Ranking
1441

Research.com Recognitions

  • 1997 - Fellow of the American Academy of Arts and Sciences

Overview

Stephen L. Hauser is affiliated with the University of California, San Francisco in the United States. Their main field of study is Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Immunology, Neurology, Rheumatology, and Oncology.

The research topics covered by Stephen L. Hauser span multiple areas with an emphasis on Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, T-cell and B-cell Immunology, Polyomavirus and related diseases, Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, and Immunotherapy and Immune Responses.

Among their recent papers, the following have been published:

  • Treatment of Multiple Sclerosis: A Review, 2020, The American Journal of Medicine
  • Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials, 2020, JAMA Neurology
  • Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course, 2022, Cell
  • Role of B Cells in Multiple Sclerosis and Related Disorders, 2020, Annals of Neurology
  • KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19, 2022, Science

Frequent co-authors collaborating with Stephen L. Hauser include:

  • Bruce Cree
  • Ludwig Kappos
  • Jorge R. Oksenberg
  • Xavier Montalbán
  • Riley Bove

Their work is often published in established journals and venues such as:

  • Neurology
  • Multiple Sclerosis Journal
  • Annals of Neurology
  • Journal of Neurology Neurosurgery & Psychiatry
  • Multiple Sclerosis and Related Disorders

Stephen L. Hauser has been recognized as a Fellow of the American Academy of Arts and Sciences since 1997.

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

    Stephen L. Hauser;Emmanuelle Waubant;Douglas L. Arnold;Timothy Vollmer

  • Risk alleles for multiple sclerosis identified by a genomewide study.

    David A. Hafler;Alastair Compston;Stephen Sawcer;Mark J. Daly

  • Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

    Stephen L. Hauser;Amit Bar-Or;Giancarlo Comi;Gavin Giovannoni

  • Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

    Xavier Montalban;Stephen L. Hauser;Ludwig Kappos;Douglas L. Arnold

  • Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

    Walter J. Curran;Rebecca Paulus;Corey J. Langer;Ritsuko Komaki

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Identification of autoantibodies associated with myelin damage in multiple sclerosis

    Claude P. Genain;Barbara Cannella;Stephen L. Hauser;Cedric S. Raine

  • Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial†

    Kathleen Hawker;Paul O'Connor;Mark S. Freedman;Peter A. Calabresi

  • Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.

    Egle Cekanaviciute;Bryan B. Yoo;Tessel F. Runia;Justine W. Debelius

  • The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.

    Stephen L. Hauser;Jorge R. Oksenberg

  • Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

    Hauser Sl;Dawson Dm;Lehrich;Beal Mf

  • Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

    Philip L De Jager;Philip L De Jager;Xiaoming Jia;Joanne Wang;Paul I W de Bakker

  • Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

    Ludwig Kappos;David Li;Peter A Calabresi;Paul O'Connor

  • Treatment of Multiple Sclerosis: A Review

    Stephen L. Hauser;Bruce A.C. Cree

  • Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis

    Simon G. Gregory;Silke Schmidt;Puneet Seth;Jorge R. Oksenberg

  • A COMPLETE GENOMIC SCREEN FOR MULTIPLE SCLEROSIS UNDERSCORES A ROLE FOR THE MAJOR HISTOCOMPATIBILITY COMPLEX

    Haines Jl;Ter-Minassian M;Bazyk A;Gusella Jf

  • INCIDENTAL MRI ANOMALIES SUGGESTIVE OF MULTIPLE SCLEROSIS: THE RADIOLOGICALLY ISOLATED SYNDROME

    Darin Okuda;E. M. Mowry;A. Beheshtian;E. Waubant

  • Ofatumumab versus Teriflunomide in Multiple Sclerosis

    Stephen L. Hauser;Amit Bar-Or;Jeffrey A. Cohen;Giancarlo Comi

  • Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.

    Feng Mei;Stephen P J Fancy;Yun-An A Shen;Jianqin Niu

  • T cell gelatinases mediate basement membrane transmigration in vitro.

    D Leppert;E Waubant;R Galardy;N W Bunnett

  • Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

    Sergio E. Baranzini;Joanne Wang;Rachel A. Gibson;Nicholas Galwey

Frequent Co-Authors

Jorge R. Oksenberg
Jorge R. Oksenberg University of California, San Francisco
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Lisa F. Barcellos
Lisa F. Barcellos University of California, Berkeley
David A. Hafler
David A. Hafler Yale University
Bruce A. C. Cree
Bruce A. C. Cree University of California, San Francisco
S. Claiborne Johnston
S. Claiborne Johnston The University of Texas at Austin
Sergio E. Baranzini
Sergio E. Baranzini University of California, San Francisco
Margaret A. Pericak-Vance
Margaret A. Pericak-Vance University of Miami
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Howard L. Weiner
Howard L. Weiner Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare careers, including roles in nursing and specialized patient care. For those interested in entering the nursing field quickly, exploring lpn programs easy to get into can be a practical starting point. Licensed Practical Nurses provide essential support in clinical settings, often serving as a foundation for further advancement.

For students aiming to expand their qualifications, the easiest np programs to get into offer accessible routes to becoming Nurse Practitioners. These programs can be completed online, allowing for greater flexibility and balancing of work-life demands.

Specializing further in mental health, online options such as the best online pmhnp programs provide excellent clinical placement opportunities. These are vital for gaining hands-on experience in psychiatric nursing.

Cost is also a significant consideration. Prospective students may want to review cheapest pmhnp programs online to find quality education options that fit their budget while preparing them for a rewarding career in healthcare and immunology-related fields.

Best Scientists Citing Stephen L. Hauser

Trending Scientists

Recently Published Articles